Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Kenneth J. Widder
Leeftijd : 67
Vermogen : 2 067 326 USD
Belangrijkste bedrijven : Quidel Corporation - Evoke Pharma, Inc.
Overzicht 
Founder of Santarus, Inc., Molecular Biosystems, Inc., FeRx, Inc. and NovaCardia, Inc., Kenneth J. Widder is an entrepreneur and businessperson who has been at the head of 7 different companies and currently holds the position of Executive Chairman at OrphoMed, Inc., Chairman & Chief Executive Officer for Sydnexis, Inc. and Partner at Latterell Venture Partners. Dr. Widder is also on the board of 6 other companies.

He previously occupied the position of Chairman & Chief Executive Officer of Converge Medical, Inc., Managing Member at Windamere Venture Partners LLC, Chairman & Chief Executive Officer for Molecular Biosystems, Inc., Chairman of Santarus, Inc., Chairman for Sytera, Inc. and Chief Executive Officer for NovaCardia, Inc.

Dr. Widder received an undergraduate degree from Carleton College and a graduate degree and a doctorate from Northwestern University.


Posities en verantwoordelijkheden van Kenneth J. Widder 
NaamTitel Van
Quidel Corporation
(Geavanceerde medische apparatuur & technologie)
Independent Director 2014
Evoke Pharma, Inc.
(Farmaceutische producten)
Independent Director 2007
OrphoMed, Inc. Executive Chairman 2017
Meritage Pharma, Inc. Director -
Naurex, Inc. Director -
San Diego Museum of Art Director -
The Vision of Children Foundation Director -
Sydnexis, Inc. Chairman & Chief Executive Officer 2017
Latterell Venture Partners Partner -


Belangnemingen van Kenneth J. Widder 
NaamAandelen%Totale waarde
Quidel Corporation (QDEL)
(Geavanceerde medische apparatuur & technologie)
16 0320,039%2 067 326 USD
Evoke Pharma, Inc. (EVOK)
(Farmaceutische producten)
00,0000%0 USD


Kenneth J. WidderPersoonlijk netwerk 
Meest gelezen nieuws 
22/09WILLIAM ACKMAN : Ackman's Pershing Square fonds stijgt bij beursdebuut Universal
MR
24/09CATHIE WOOD : Chinese maatregelen tegen bitcoin opnieuw een klap voor Cathie Woods ARK ETF
MR
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
13/09MARTIN SORRELL : Sorrell's S4 Capital verhoogt winstverwachting tot 40%
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Kenneth J. Widder Verbindingen